1. Home
  2. QSR vs TEVA Comparison

QSR vs TEVA Comparison

Compare QSR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSR
  • TEVA
  • Stock Information
  • Founded
  • QSR 1954
  • TEVA 1901
  • Country
  • QSR Canada
  • TEVA Israel
  • Employees
  • QSR N/A
  • TEVA N/A
  • Industry
  • QSR
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • QSR
  • TEVA Health Care
  • Exchange
  • QSR Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • QSR N/A
  • TEVA 20.1B
  • IPO Year
  • QSR 2006
  • TEVA N/A
  • Fundamental
  • Price
  • QSR $67.91
  • TEVA $16.65
  • Analyst Decision
  • QSR Buy
  • TEVA Strong Buy
  • Analyst Count
  • QSR 19
  • TEVA 8
  • Target Price
  • QSR $77.74
  • TEVA $24.50
  • AVG Volume (30 Days)
  • QSR 4.0M
  • TEVA 10.6M
  • Earning Date
  • QSR 08-07-2025
  • TEVA 07-30-2025
  • Dividend Yield
  • QSR 3.65%
  • TEVA N/A
  • EPS Growth
  • QSR N/A
  • TEVA N/A
  • EPS
  • QSR 2.94
  • TEVA N/A
  • Revenue
  • QSR $8,776,000,000.00
  • TEVA $16,616,000,000.00
  • Revenue This Year
  • QSR $9.51
  • TEVA $5.69
  • Revenue Next Year
  • QSR $3.22
  • TEVA N/A
  • P/E Ratio
  • QSR $23.13
  • TEVA N/A
  • Revenue Growth
  • QSR 22.38
  • TEVA 3.82
  • 52 Week Low
  • QSR $58.71
  • TEVA $12.47
  • 52 Week High
  • QSR $75.07
  • TEVA $22.80
  • Technical
  • Relative Strength Index (RSI)
  • QSR 52.55
  • TEVA 45.87
  • Support Level
  • QSR $64.44
  • TEVA $16.42
  • Resistance Level
  • QSR $68.38
  • TEVA $16.95
  • Average True Range (ATR)
  • QSR 1.14
  • TEVA 0.46
  • MACD
  • QSR -0.11
  • TEVA -0.11
  • Stochastic Oscillator
  • QSR 71.69
  • TEVA 16.79

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: